pop up description layer
  lauftext +++ lauftext +++ lauftext +++ lauftext +++ lauftext +++ lauftext +++ lauftext +++ lauftext +++ lauftext +++ lauftext +++ lauftext +++ lauftext +++ lauftext +++ lauftext +++ lauftext +++ lauftext +++  
 
Symposia contacts
Hall overview
Organisation guideOrganisation guide
Industry Meeting RoomsTechnical details
Promotional servicesPromotional services
Industry meeting roomsIndustry meeting rooms
 
 
 
 
 
EASD Registration Scientific Programme
Congrex

 

 Back to Symposia overview

FROM BARIATRIC SURGERY TO METABOLIC INTERVENTIONS: WHAT IS THE CURRENT EVIDENCE TELLING US? WHAT ARE FUTURE PROSPECTS TO TREAT METABOLIC DISORDERS?

Monday, 20 September 2010, 10:00 – 12:30
Hall T6

Chair: Prof. Luc Van Gaal, BE  
10:00 – 10:30 Welcome and Introduction
From bariatric surgery to metabolic interventions
Prof. Luc Van Gaal, BE		  
10:30 – 11:00 Effects of bariatric surgery on diabetes, cardiovascular disease and cancer. SOS experiences over 20 years.
Prof. Lars Sjöström, SE		  
11:00 – 11:20 Status quo of evidence: Metabolic effects of bariatric surgery with special focus on the outcomes on Type II Diabetes Mellitus
Prof. Andreas Hamann, DE		  
11:20 – 11:40 New scientific approach to understand the mechanisms of action of surgery and to find new solutions to treat metabolic disorders
Dr. Martin Fried, CZ		  
11:40 – 12:20 Outcomes of current research on the mechanisms of action of surgery on metabolic disorders especially Type II Diabetes Mellitus
Dr. Randy Seeley, US		  
12:20 – 12:30 Closing  




Sponsor: Ethicon Endo-Surgery Johnson & Johnson Ethicon Endo-Surgery Johnson & Johnson
 
 print this page  
         
 
© 2010 EASD | Contact | Imprint

ExhibitionSymposia General